Fig. 4
From: A novel in vitro model for the assessment of postnatal myonuclear accretion
Increased in vitro postnatal myonuclear accretion in C2C12 cells upon IL-13 and IL-4 treatment. Luciferase-based assessment of myonuclear accretion 3 days after initiation of co-culturing +/− 250 ng/mL IL-13 (a-c) or 500 ng/mL IL-4 (d-f). a Luciferase activity (RLU) per well, b protein content (μg/μL) per well, c relative luciferase activity (RLU/protein content) per well, d luciferase activity (RLU) per well, e protein content (μg/μL) per well, f relative luciferase activity (RLU/protein content) per well. Values are means ± SEM, n = 4. *p < 0.05, ***p < 0.001